LifeSci Venture Partners

Seed to Series B venture capital firm

LifeSci Venture Partners is a Seed to Series B venture capital firm that typically writes $500K–$15M checks in Biotechnology, Medical Devices and Digital Health. DryPowder has no SEC Form D on file for LifeSci Venture Partners as of September 12, 2026. Partners at LifeSci Venture Partners include Bruce Booth (Partner).

Updated · Sources: fund website

Typical check
$500K–$15M
Stages
Seed–Series B

Overview

LifeSci Venture Partners at a glance

Stage
Seed, Series A, Series B
Check size
$500K–$15M
Sectors
Biotechnology, Medical Devices, Digital Health, Pharmaceuticals

Investment thesis

Invests in early-stage life sciences companies developing breakthrough therapeutics, medical devices, and healthcare technologies

Stated on lifescivc.comWEBSITE

Partners

1 partner at LifeSci Venture Partners

Similar funds

Funds like LifeSci Venture Partners

Investor lists that include LifeSci Venture Partners

FAQ

Questions about LifeSci Venture Partners

What does LifeSci Venture Partners invest in?

LifeSci Venture Partners is a Seed, Series A, Series B stage Biotechnology, Medical Devices, Digital Health, Pharmaceuticals investor, typically writing $500K – $15M checks, primarily investing in United States. Their thesis: Invests in early-stage life sciences companies developing breakthrough therapeutics, medical devices, and healthcare technologies

What check size does LifeSci Venture Partners write?

LifeSci Venture Partners typically writes $500K – $15M checks at the Seed, Series A, Series B stage in Biotechnology, Medical Devices, Digital Health, Pharmaceuticals.

What other funds are similar to LifeSci Venture Partners?

Funds with an overlapping stage and sector focus include M13, 1984 Ventures, 3one4 Capital.